First, the surface expression profile of CLL B cells shows that they are CD19+, CD5+, CD23+, IgM+, IgDlow, and CD79blow-, indicating a mature B-cell phenotype [8]. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.